Neurofilaments in blood and CSF for diagnosis and prediction of onset in Creutzfeldt-Jakob disease
Year: 2016
Type: article
Study design: Observational Study
Abstract: While cerebrospinal fluid (CSF) biomarkers for Creutzfeldt-Jakob disease (CJD) are established and partly included in the diagnostic criteria, no blood biomarkers are available. Here, we assessed the utility of serum neurofilament light chain (NF-L) and tau protein in comparison to CSF markers (NF-L and phosphorylated NF heavy chain (pNF-H), tau, S100B, 14-3-3) and prion conversion assay (real-time quaking induced conversion (RT-QuIC)) for sporadic and genetic CJD. Importantly, a Gerstmann-Sträussler-Scheinker mutation carrier in the asymptomatic phase and at disease onset was included as well. Both NF-L and tau were markedly increased in CJD serum, reaching similar or even better performance as in CSF (sensitivity and specificity for serum NF-L 100% and 85.5%, and for serum tau 84.6% and 96.2%, respectively). Serum S100B showed high sensitivity as well (84.2%), but lower specificity (63%). CSF neurofilaments were increased before symptom onset, while prion seeding assay was negative. Just before a clinical diagnosis could be made, all CSF markers and NF-L in the serum were increased and CSF prion conversion assay was positive. The data suggest that neurofilaments are sensitive and specific blood markers for the diagnosis of genetic and sporadic CJD and might represent promising tools to predict disease onset.
Source: Scientific Reports
DOI: 10.1038/srep38737
Authors: Petra Steinacker, Kaj Blennow, Steffen Halbgebauer, Song Shi, Viktoria Ruf, Patrick Oeckl, Armin Giese, Jens Kuhle, Dana Slivarichova, Henrik Zetterberg, Markus Otto
Institutions: Universität Ulm, Sahlgrenska University Hospital, University of Gothenburg, Institut für Neuropathologie, Ludwig-Maximilians-Universität München, University Hospital of Basel, Slovak Medical University, National Hospital for Neurology and Neurosurgery, UCL Queen Square Institute of Neurology, University College London
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $2,690
Awards: G2256545304, G2325242462, JPND Verbundprojekt BIOMARKAPD, Aufbau einer Biomaterialbank und eines Ausbildungsprogramms zur internationalen Harmonisierung, JPND-Verbundprojekt PreFrontALS: 'Suche nach therapeutischen Interventionen bei Patientinnen und Patienten mit der frontotemporalen Demenz und einer genetischen Mutation - der sogenannten C9ORF72-Expansion - im präsymptomatischen Erkrankungsstadium', JPND Verbundprojekt SOPHIA: Probensammlung, Optimierung und Harmonisierung von Biomarkern bei ALS und anderen Motoneuronenerkrankungen (Universität Ulm), G3685286283, G404723870, G4249494015, Verbundprojekt: Kompetenznetz Demenzen - FTLD: Teilprojekte der Universität Ulm, G4357802935, G4467593454, G5006157615, Nanosystems for the early Diagnosis of Neurodegenerative diseases, Pathways to Alzheimer's disease, G7547206763
OpenAlex ID: W2559843302
